Actuate Therapeutics, Common Stock Alpha and Beta Analysis
| ACTU Stock | 6.56 0.05 0.76% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Actuate Therapeutics, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Actuate Therapeutics, over a specified time horizon. Remember, high Actuate Therapeutics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Actuate Therapeutics,'s market risk premium analysis include:
Beta 1.22 | Alpha (0.11) | Risk 3.98 | Sharpe Ratio (0.0004) | Expected Return (0) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Actuate Therapeutics, Backtesting, Actuate Therapeutics, Valuation, Actuate Therapeutics, Correlation, Actuate Therapeutics, Hype Analysis, Actuate Therapeutics, Volatility, Actuate Therapeutics, History and analyze Actuate Therapeutics, Performance. Actuate Therapeutics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Actuate Therapeutics, market risk premium is the additional return an investor will receive from holding Actuate Therapeutics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Actuate Therapeutics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Actuate Therapeutics,'s performance over market.| α | -0.11 | β | 1.22 |
Actuate Therapeutics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Actuate Therapeutics,'s Buy-and-hold return. Our buy-and-hold chart shows how Actuate Therapeutics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Actuate Therapeutics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Actuate Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actuate Therapeutics, shares will generate the highest return on investment. By understating and applying Actuate Therapeutics, stock market price indicators, traders can identify Actuate Therapeutics, position entry and exit signals to maximize returns.
Actuate Therapeutics, Return and Market Media
The median price of Actuate Therapeutics, for the period between Fri, Sep 26, 2025 and Thu, Dec 25, 2025 is 6.96 with a coefficient of variation of 8.38. The daily time series for the period is distributed with a sample standard deviation of 0.58, arithmetic mean of 6.92, and mean deviation of 0.47. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Can Actuate Therapeutics Inc. stock beat analyst upgrades - Market Growth Report Expert Verified Movement Alerts - nchmf.gov.vn | 10/17/2025 |
2 | Disposition of 50000 shares by Beitzel George B of Actuate Therapeutics, at 1.49 subject to Rule 16b-3 | 11/21/2025 |
3 | Backbone Potential Actuates Elraglusib Shows Promise vs. Pancreatic Cancer - GEN - Genetic Engineering and Biotechnology News | 11/25/2025 |
4 | Research Analysts Weekly Ratings Updates for Actuate Therapeutics | 12/03/2025 |
5 | Disposition of 10000 shares by Beitzel George B of Actuate Therapeutics, at 1.99 subject to Rule 16b-3 | 12/18/2025 |
About Actuate Therapeutics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Actuate or other stocks. Alpha measures the amount that position in Actuate Therapeutics, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 | 2025 (projected) | Current Ratio | 4.71 | 0.43 | 1.05 | 0.99 | Net Debt To EBITDA | 1.02 | 0.12 | 0.33 | 0.54 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Actuate Therapeutics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Actuate Therapeutics,'s short interest history, or implied volatility extrapolated from Actuate Therapeutics, options trading.
Build Portfolio with Actuate Therapeutics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Actuate Stock Analysis
When running Actuate Therapeutics,'s price analysis, check to measure Actuate Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actuate Therapeutics, is operating at the current time. Most of Actuate Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Actuate Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actuate Therapeutics,'s price. Additionally, you may evaluate how the addition of Actuate Therapeutics, to your portfolios can decrease your overall portfolio volatility.